We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-0.62%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.63B
AUM Growth
+$871M
Cap. Flow
-$403M
Cap. Flow %
-7.15%
Top 10 Hldgs %
32.98%
Holding
166
New
29
Increased
30
Reduced
12
Closed
23

Top Buys

Rank Stock Value
1
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
+$235M
2
AHCO icon
AdaptHealth
AHCO
+$145M
3
CMAX
CareMax, Inc. Class A Common Stock
CMAX
+$132M
4
ORGO icon
Organogenesis Holdings
ORGO
+$78.8M
5
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$50.1M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$110M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$88.6M
3
BIIB icon
Biogen
BIIB
+$86.7M
4
CNC icon
Centene
CNC
+$67.9M
5
TOI icon
The Oncology Institute
TOI
+$55M

Sector Composition

Rank Sector Weight
1 Healthcare 68.23%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDVL
76
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$14M 0.25%
22,851
– –
RNAM
77
DELISTED
Avidity Biosciences
RNAM
$13.8M 0.25%
560,132
+106,159
+23% +$2.47M
BVS icon
78
Bioventus
BVS
$799M
$13.7M 0.24%
778,567
-178,433
-19% -$2.88M
PRVA icon
79
Privia Health
PRVA
$3.21B
$13.3M 0.24%
+300,000
New +$11.1M
AERI
80
DELISTED
Aerie Pharmaceuticals
AERI
$13.2M 0.23%
825,937
+331,721
+67% +$5.69M
ANNX icon
81
Annexon
ANNX
$855M
$13.1M 0.23%
583,913
– –
COGT icon
82
Cogent Biosciences
COGT
$6.79B
$13M 0.23%
1,601,000
+601,000
+60% +$5.08M
BDTX icon
83
Black Diamond Therapeutics
BDTX
$101M
$12.8M 0.23%
1,047,599
– –
CNVY
84
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$12.5M 0.22%
+1,100,000
New +$12.7M
AMWL icon
85
American Well
AMWL
$181M
$12.5M 0.22%
49,556
– –
AGL icon
86
Agilon Health
AGL
$1.64B
$12.2M 0.22%
+12,000
New +$10.5M
GHRS icon
87
GH Research
GHRS
$1.87B
$12.1M 0.21%
+555,416
New +$11.3M
CVRX icon
88
CVRx
CVRX
$126M
$11.2M 0.2%
+400,000
New +$11.2M
LFST icon
89
Lifestance Health
LFST
$4.16B
$11.1M 0.2%
+400,000
New +$10.6M
SRSAU
90
DELISTED
Sarissa Capital Acquisition Corp. Unit
SRSAU
$10.4M 0.19%
1,000,000
– –
BCAB icon
91
BioAtla
BCAB
$5.59M
$10.4M 0.18%
4,908
+800
+19% +$1.81M
EUCRU
92
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$10.2M 0.18%
1,000,000
– –
SNRHU
93
DELISTED
Senior Connect Acquisition Corp. I Unit
SNRHU
$10.1M 0.18%
1,000,000
– –
REVHU
94
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
$10.1M 0.18%
1,000,000
– –
MTACU
95
DELISTED
MedTech Acquisition Corporation Unit
MTACU
$10M 0.18%
1,000,000
– –
ADVM
96
DELISTED
Adverum Biotechnologies
ADVM
$9.89M 0.18%
282,700
+42,256
+18% +$2.28M
CMIIU
97
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
$8.07M 0.14%
600,000
– –
GLUE icon
98
Monte Rosa Therapeutics
GLUE
$1.92B
$7.95M 0.14%
+350,000
New +$7.13M
OKUR
99
OnKure Therapeutics
OKUR
$166M
$7.92M 0.14%
+84,930
New +$9.47M
OLMA icon
100
Olema Pharmaceuticals
OLMA
$1.02B
$7.59M 0.13%
271,191
– –
2 3
4
5 6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2021 Portfolio in Review

As of Q2 2021, Deerfield Management held 166 positions worth $5.63B, up 18% from $4.76B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Deerfield Management withdrew a net $403M in Q2 2021, closing 23 positions and reducing 12 holdings. Its most notable exit was Boston Scientific, an estimated $110M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 71% a quarter earlier, followed by Consumer Discretionary.

Against the trend, Deerfield Management opened a new position in Singular Genomics Systems, Inc. Common Stock worth $250M.

  • Deerfield Management's largest Q2 2021 buy was Singular Genomics Systems, Inc. Common Stock: 303,734 shares worth $250M.
  • Deerfield Management added most to AdaptHealth in Q2 2021, an estimated $145M increase.
  • Deerfield Management's biggest Q2 2021 reduction was Centene, cutting an estimated $67.9M.
  • Deerfield Management fully exited Boston Scientific in Q2 2021, selling an estimated $110M.
  • Deerfield Management's ten largest holdings make up 33% of its $5.63B portfolio in Q2 2021.
  • Deerfield Management opened 29 new positions and closed 23 in Q2 2021.
  • Deerfield Management's portfolio value rose 18% quarter-over-quarter to $5.63B.

Based on Deerfield Management's 13F filing for Q2 2021, filed 16 Aug 2021.